Get in touch

Medical Device Market Authorization

Advisory on securing MDMA, SFDA approvals, and global authorization pathways for regional and international market entry.

Built for Companies Seeking Market Approval

We help medical device and IVD manufacturers prepare authorization strategies for Saudi Arabia, GCC markets, and selected international pathways.

First-Time Applicants

Understand the authorization route, documentation needs, and authority expectations before submission.

International Manufacturers

Identifying regulatory overlaps to reduce redundant work by reviewing technical and clinical files to ensure compliance with regulatory requirements.

Regional Distributors

Clarify MDMA responsibilities, product data needs, and submission readiness before market entry.

Portfolio Owners

Plan authorization priorities across multiple devices, classes, and regional markets.

Authorization Support From Strategy to Submission

We structure the route to approval by aligning classification, evidence, documentation, and authority requirements before submission.

Authorization Pathway Strategy

We define the appropriate MDMA and market entry route based on device type, risk class, evidence, and target markets.

Submission Readiness Review

We assess technical file, labeling, certificates, QMS evidence, and administrative documents against authority expectations.

MDMA Package Preparation

We support assembly of clear, complete submission materials for Saudi medical device market authorization.

Authority Interaction Support

We help manage clarification requests, deficiency responses, and regulatory communications during review.

Regional Expansion Planning

We connect Saudi authorization strategy with GCC and international market entry priorities where applicable.

How We Work

A practical workflow for moving from market entry goals to authorization-ready submission.

Classify

Confirm device category, risk class, and applicable regulatory pathway.

Assess

Review evidence, certificates, labeling, and technical documentation readiness.

Prepare

Organize submission files, declarations, and administrative requirements.

Submit

Support application handling, authority questions, and deficiency responses.

Expand

Plan follow-on approvals, renewals, and regional market entry steps.

Key Deliverables

Clear outputs that drive compliance, reduce risk, and accelerate your time to market.

01

Authorization Strategy Memo

A concise market entry route covering MDMA and regional approval priorities.

02

Submission Readiness Checklist

A practical review of documents, evidence, and administrative gaps.

03

MDMA Documentation Pack

Organized materials prepared for Saudi medical device authorization workflows.

04

Deficiency Response Support

Structured support for authority questions and required corrective clarifications.

05

Regional Entry Roadmap

Recommended next steps for GCC or international market expansion after approval.

Build a Complete Regulatory Ecosystem .

LexoraMed provides integrated regulatory support across Saudi Arabia, GCC, and global markets — helping manufacturers move from strategy to authorization with confidence and clarity.

Medical Device Market Authorization

Advisory on securing MDMA, SFDA approvals, and global authorization pathways for regional and international market entry.

Read More

Technical File Assessment

Leading comprehensive reviews of innovative device dossiers, successfully translating advanced clinical data, cybersecurity parameters, and biocompatibility profiles into robust regulatory submissions.

Read More

Post-Market Surveillance

Ongoing compliance, vigilance, safety monitoring, reporting, and lifecycle support after market authorization.

Read More

Frequently Asked Questions

Clear answers to the most common regulatory and compliance questions manufacturers ask before entering Saudi Arabia and global markets.

What is MDMA? +
MDMA refers to Medical Device Marketing Authorization, the SFDA route used to authorize eligible medical devices for placement on the Saudi market.
Can existing CE or FDA documentation support Saudi authorization? +
Yes, existing approvals and technical evidence can be useful, but they must be mapped to SFDA requirements and the device's Saudi regulatory pathway.
Do you support both devices and IVDs? +
Yes. We support authorization planning for medical devices and IVDs, with the pathway determined by classification and intended use.
Can one strategy cover Saudi Arabia and other GCC markets? +
A coordinated strategy is possible, but each market may still require specific documentation, local responsibilities, and authority interactions.